Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ARUK 2022 | Epigenetics in prion diseases

Emmanuelle Viré • 2 Mar 2022
ARUK 2022
Dementia

Emmanuelle Viré, PhD, Institute of Prion Diseases, University College London, London, explains the potential of epigenetic inhibitors in the treatment of neurodegenerative disease and how prion diseases are being used as a model. Dr Vire also discusses current research on a single cell experiment in an animal model of prion disease which has potentially identified a very early stage of disease. This interview took place at the Alzheimer’s Research UK Conference 2022 in Brighton, UK.

More from Emmanuelle Viré

Research into the effect of the gut microbiome on Alzheimer's disease at ARUK 2022
1:45
Research into the effect of the gut microbiome on Alzheimer's disease at ARUK 2022
Emmanuelle Viré • 2 Mar 2022

Related Videos

A multimodal model to detect and stage Alzheimer's disease using MRI, acoustic signals, and genetics
10:28
A multimodal model to detect and stage Alzheimer's disease using MRI, acoustic signals, and genetics
Muhammad Umar Khan • 28 Aug 2026
Neuroprotective effects of aortic valve replacement: a propensity score-matched cohort study
3:25
Neuroprotective effects of aortic valve replacement: a propensity score-matched cohort study
Vikash Jaiswal • 26 Aug 2026
The Lewy Body Society's mission and impact
2:38
The Lewy Body Society's mission and impact
Jacqui Cannon • 5 Aug 2026
Neflamapimod receives ILAP designation in the UK for dementia with Lewy bodies
2:44
Neflamapimod receives ILAP designation in the UK for dementia with Lewy bodies
Jacqui Cannon • 5 Aug 2026

Choose your cookie settings

VJDementia uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJDementia is intended for healthcare professionals